News  Donate!

Current Studies and Trials

Current trial participants should view our short Clinical Trials Training Video to familiarize yourself with the clinical trials process and important do's and don'ts, such as what content is appropriate to share publicly.

We strongly encourage you to join registries, including the Myotonic Dystrophy Family Registry and the DM and FSHD Registry at the University of Rochester, and make sure you update your information annually. You also may have an opportunity to participate in biobanks and follow organizations like the Myotonic Dystrophy Foundation to make sure you have current information regarding progress and research needs.

Visit the full Study & Trial Resource Center to find additional resources for participants as well as a list of frequently asked questions.

See the list below for information on current studies and trials.

Status: Enrolling by invitation

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

Conditions: Myotonic Dystrophy Type 1
Location: Multiple sites
Sponsor: Myotonic Dystrophy Clinical Research Network
Contact: Co-PIs Drs. Charles Thornton and Nicholas Johnson; see site-specific contact information below

If you are interested in this research study, please contact one of the study coordinators listed below or or Jeanne Dekdebrun at Jeanne_Dekdebrun@urmc.rochester.edu or Jessica St. Romain at Mary.StRomain@vcuhealth.org.

Recruiting:

Status: Partial Hold

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients (MARINA)

Conditions: Myotonic Dystrophy Type 1
Location: Multiple sites
Sponsor: Avidity Biosciences, Inc.
Contact: Avidity Biosciences, Inc.at 858-771-7038 or by email at medinfo@aviditybio.com.

Recruiting:

  • University of California Los Angeles (UCLA), Los Angeles, California

  • Stanford University, Palo Alto, California

  • University of Florida, Gainesville, Florida

  • Kansas University Medical Center, Kansas City, Kansas

  • University of Rochester Medical Center, Rochester, New York

  • Ohio State University, Columbus, Ohio

  • Virginia Commonwealth University, Richmond, Virginia

Not yet recruiting:

  • University of Colorado, Denver, Colorado

Status: Recruiting

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Conditions: Myotonic Dystrophy Type 1
Location: Multiple sites
Sponsor: Harmony Biosciences, LLC
Contact: Ann Adee at 773-383-6258, Michelle Manuel at 847-903-4610, or email clinicaltrials@harmonybiosciences.com. See site-specific contact information below

Recruiting:

Not yet recruiting:

Status:Recruiting

Efficacy and Safety of Tideglusib in Congenital Myotonic Dystophy

Conditions: Congenital Myotonic Dystrophy, ages 6 to 16, can swallow or can take liquid study medicine by a gastronomy tube.
Location: Multiple sites
Sponsor: AMO Pharma Limited
Contact:
Recruiting:

Not yet recruiting:

  • Los Angeles, CA, University of California, Los Angeles (UCLA)
  • Pittsburgh, PA, Children's Hospital of the King's Daughters
  • Pittsburgh, PA, Virginia Commonwealth University - Department of Neurology. Muscular Dystrophy Translational Research Program
  • Newcastle Upon Tyne, United Kingdom, Newcastle University

Status: Recruiting

Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2 (BraCE-DM2)

Conditions: Confirmed and symptomatic DM2, Ages 35+, no history of active psychiatric and neurological disorders, can walk 10-meter independently (cane and walking sticks are permitted), be able to participate in an MRI, and not pregnant.
Location: Winston-Salem, NC
Sponsor: National Institute of Health (NIH)
Contact: Constance Linville, 336-716-4568, clinvill@wakehealth.edu

Status: Recruiting

Cognitive Function and Neuroimaging in Myotonic Dystrophy

Conditions: Males and females, ages 7 to 17 years-old, who have been diagnosed with CDM or childhood onset DM1.
Location: Salt Lake City, UT
Sponsor: University of Utah
Contact: Study Coordinator, Becky Crockett at 801-585-1676 or at becky.crockett@hsc.utah.edu

Status: Recruiting

Biomarker Development for Muscular Dystrophies

Conditions: Confirmed DM1 or DM2. Males and females ages 14 and older. In addition, male and female healthy volunteers ages 18 and older who are family members of an individual with muscular dystrophy also are invited to participate.
Location: Boston, MA
Sponsor: Massachusetts General Hospital
Contact: Thurman Wheeler, MD or Alex Sizemore, 617-726-7506

Status: Recruiting

Biomarker Development for Muscular Dystrophies

Conditions: Confirmed DM1 or DM2. Males and females ages 5 and older. In addition, male and female healthy volunteers ages 18 and older who are family members of an individual with muscular dystrophy also are invited to participate.
Location: Boston, MA
Sponsor:

  • Boston Children's Hospital
  • Massachusetts General Hospital
  • Brigham and Women's Hospital

Contact:

  • Thurman Wheeler, MD or Alex Sizemore, 617-726-7506
  • Basil Darras, MD, or Rachael Titus, 617-919-1806
  • Anthony Amato, MD, 857-307-1445

Status: Recruiting

Extracellular RNA biomarkers of myotonic dystrophy

Conditions: Confirmed DM1 or DM2. Males and females ages 5 and older. In addition, male and female healthy volunteers ages 18 and older who are family members of an individual with muscular dystrophy also are invited to participate.
Location: Boston, MA
Sponsor:

  • Massachusetts General Hospital
  • Brigham and Women’s Hospital
  • Beth Israel Deaconess Medical Center

Contact:

  • Thurman Wheeler, MD or Ningyan Hu, MS, 617-726-7506
  • Marie Guthrie or Louis Beers, 857-307-1445
  • Hilda Gutierrez, MD, 617-667-3086

Status: Recruiting

Study of Pathogenesis and Progression in DM (STOPP-DM2)

Conditions: DM2 ages 18-80 still open for enrollment; DM1 enrollment is closed
Location: University of Rochester, Rochester, NY
Sponsor: NIH
Contact: Jeanne Dekdebrun, M.S., (585)276-4611

Status: Recruiting

Myotonic Dystrophy Family Registry

Conditions: All types of DM
Location: Online/Global
Sponsor: Myotonic Dystrophy Foundation

Status: Recruiting

Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry

Conditions: DM1; DM2; Congenital Myotonic Dystrophy; Muscular Dystrophy
Location: Rochester, NY
Sponsor:

  • University of Rochester
  • National Institute of Neurological Disorders and Stroke (NINDS)

Contact: Registry Coordinator, (888)925-4302

Status: Recruiting

Characterization of Sleep, Neuropsychology and Brain Changes in Adults with Myotonic Dystrophy Type 1

Conditions: DM1 and Unaffected
Location: Stanford, CA (Including Stanford Center for Sleep Sciences and Medicine)
Sponsor: NIH/Investigator-Initiated
Contact: Stanford Neuromuscular Research Line (650)725-4341

Status: Recruiting

Insulin Resistance and Insulin Secretion in Patients with Myotonic Dystrophy

Conditions: DM1
Location: Stanford, CA
Sponsor: Stanford University
Contact: Stanford Neuromuscular Research Line (650)725-4341

Status: Recruiting

Characterizing the Sleep and Gastrointestinal Changes in Adults with Myotonic Dystrophy (Questionnaire-based)

Conditions: Myotonic Dystrophy
Location: Stanford, CA
Sponsor: Stanford University
Contact: Stanford Neuromuscular Research Line 650-725-4341

Status: Recruiting

Venous Thromboembolism in Myotonic Dystrophy Type 1 (DM1-VTE)

Conditions: Myotonic Dystrophy Type 1
Location: Service de Cardiologie - Hôpital Cochin, France
Sponsor:

  • Assistance Publique - Hôpitaux de Paris
  • AFM-Téléthon (Funding) 
  • Recherche Clinique Paris Descartes Necker Cochin Sainte Anne

Contact: 

Status: Recruiting

Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients

Conditions: Adults (18-75) with DM1 confirmed by genetic testing
Sponsor: University of Campania "Luigi Vanvitelli"

Status: Enrolling by invitation

Derivation of Human Induced Pluripotent Stem Cells to Heritable Cardiac Arrhythmias

Conditions: All types of DM
Location: Baltimore, MD
Sponsor: Johns Hopkins University

Status: Suspended (COVID-19)

Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy (TREAT-CDM)

Conditions: Children up to age 15 with Congenital Myotonic Dystrophy
Locations:

  • Richmond, VA
  • London, Ontario, Canada
  • Milano, Italy, 20162

Sponsor:

  • Virginia Commonwealth University
  • Neuromuscular Omnicomprehensive Clinical Center
  • University of Wetern Ontario

Contact:

  • Nicholas Johnson, MD, (804)628-6439
  • Brittney A Holmberg, (804)628-6439

Status: Active, not recruiting

Kennedy Krieger DM2 Natural History Study

Conditions: Adults (18+) with DM2 confirmed by genetic testing, LVEF >35% on two-dimensional echocardiography, and permanent pacing indication according to the current guidelines
Location: Baltimore, MD
Sponsor: Kennedy Kreiger Institute
Contact: Doris G. Leung, MD, PhD, (443)923-9521

Status: Active, not recruiting

Brain Structure and Function in Adults with a Family History of DM1

Conditions: Adults (18-65 years old) diagnosed with DM1 after the age of 21 or with a family history of DM1
Location: Iowa City, IA
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Status: Unknown

Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy

Conditions: Adults with DM1
Location: Mexico City, Mexico
Sponsor: National Institute of Respiratory Diseases, Mexico
Contact: Martha G Torres Fraga, MD, +(52)555 666 8640

Status: Unknown

Defining and Managing the Neuropsychological Abnormalities of Myotonic Dystrophy in Children

Conditions: DM1 and Unaffected
Location: Stanford, CA
Sponsor:

  • Lucile Packard Children's Hospital
  • Stanford University

Contact: Stanford Neuromuscular Research Line (650)725-4341

Status: Unknown

Muscle Relaxation in Myopathies With Positive Muscle Phenomena

Conditions: Adults with DM2
Location: Nijmegen, Netherlands
Sponsor: Radboud University
Contact: Baziel G van Engelen, MD, PhD, +(31)024 361 43 08

Status: Unknown

The Myotonic Dystrophy Type 1 (DM1) Deep Phenotyping to Improve Delivery of Personalized Medicine and Assist in the Planning, Design and Recruitment of Clinical Trials (PhenoDM1)

Conditions: DM1
Location: Newcastle and London
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Contact: Nikoletta Nikolenko, M.D., Ph.D., +4478 7051 7410

Status: Unknown

Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive Ventilation in Adults with DM1

Conditions: DM1; myopathy; muscular weakness; respiratory insufficiency
Location: Paris, France
Sponsor: Assistance Publique - Hôpitaux de Paris

Status: Unknown

German Language Screening Questionnaire for Symptoms of Respiratory Muscle Weakness and Sleep-disordered Breathing in Patients With Neuromuscular Disorders

Conditions: German Adults (18-80 years old), All types of DM, patients without any type of home ventilatory support
Location: Münster, Germany
Sponsor: Westfälische Wilhelms-Universität Münster
Contact: Matthias Boentert, MD, +49-251-83 ext. 44458

Status: Unknown

Non Invasive Prenatal Testing of Single-Gene Disorders

Conditions: All types of DM
Location: Maastricht, Netherlands
Sponsor: Maastricht University Medical Center
Contact: Christine EM de Die, MD PhD, +31 4 33877859

Status: Completed

Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1

Conditions: Confirmed DM1. Ages 18-60 with the age of onset greater than 16. An Epworth Sleepiness Scale of >11 or participants who sleep an average >10 hours a day.
Location: Multiple sites
Sponsor: Expansion Therapeutics, Inc.
Contact: Anita Seto, PhD, 858-764-4290, info@expansionrx.com

Status: Completed

Developmental Brain Disorders: Parent Survey of Symptoms and Function

Conditions: Children with genetic disorders that can result in autism, developmental and intellectual disability, seizures, challenging behaviors, movement disorders, vision/hearing loss, or any combination of these problems.
Location: Online Survey
Sponsor:

  • University of Rochester, Rochester, NY
  • Cardiff University, Cardiff, Wales, United Kingdom

Contact: DBDStudy@Cardiff.ac.uk or (585) 275-9330 (secure messages can be left at this number.)

Status: Completed

NIPD on CFTC for Triplet Repeat Diseases (DIACCIMEX)

Conditions: Expectant couple (pregnant woman between 9 and 34 weeks of gestation and her spouse) at risk of transmitting a triplet-repeat related genetic disease including Myotonic Dystrophy type 1
Location:

  • Bordeaux, France

  • Montpellier, France

  • Nice, France

  • Nîmes, France

  • Rennes, France

  • Saint Brieuc, France

  • Schiltigheim, France

  • Toulouse, France

  • Sponsor: University Hospital, Montpellier

Contact:

Status: Completed

Clinical Outcome Measures in Myotonic Dystrophy Type 2 (COMEDY-2)

Conditions: Myotonic Dystrophy Type 2
Location: Friedrich-Baur-Institue, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany
Sponsor: Prof. Dr. Benedikt Schoser
Contact: Benedikt Schoser, MD

Status: Completed

Sleep Breathing Disorders, a Main Trigger for Cardiac Arrhythmias in Type 1 Myotonic Dystrophy

Conditions: DM1
Location: Grenoble, France
Sponsor: University Hospital, Grenoble
Contact: Amina Fontanell, +33 4 76 76 76 62

© Myotonic Dystrophy Foundation. All rights reserved.